Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 764,000 | 271,000 | 474,000 | 686,000 | 143,000 |
| Receivables | 1,376,000 | 1,319,000 | 1,322,000 | 1,210,000 | 1,281,000 |
| Inventories | 184,000 | 182,000 | 181,000 | 190,000 | 184,000 |
| TOTAL | $2,623,000 | $2,017,000 | $2,228,000 | $2,372,000 | $1,815,000 |
| Non-Current Assets | |||||
| PPE Net | 2,093,000 | 1,832,000 | 1,810,000 | 1,816,000 | 1,830,000 |
| Investments And Advances | 125,000 | 126,000 | 133,000 | 135,000 | 130,000 |
| Intangibles | 10,321,000 | 9,087,000 | 9,022,000 | 8,899,000 | 8,951,000 |
| Other Non-Current Assets | 933,000 | 819,000 | 761,000 | 800,000 | 756,000 |
| TOTAL | $13,472,000 | $11,864,000 | $11,726,000 | $11,650,000 | $11,667,000 |
| Total Assets | $16,095,000 | $13,881,000 | $13,954,000 | $14,022,000 | $13,482,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 603,000 | 606,000 | 906,000 | 303,000 | 304,000 |
| Accounts payable and accrued liabilities | 1,313,000 | 1,247,000 | 1,239,000 | 1,359,000 | 1,157,000 |
| TOTAL | $2,092,000 | $2,012,000 | $2,298,000 | $1,815,000 | $1,618,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,648,000 | 3,816,000 | 3,804,000 | 4,410,000 | 3,946,000 |
| aiOther Non-Current Liabilities | 1,503,000 | 1,386,000 | 1,369,000 | 1,442,000 | 1,443,000 |
| TOTAL | $7,162,000 | $5,213,000 | $5,187,000 | $5,865,000 | $5,401,000 |
| Total Liabilities | $9,254,000 | $7,225,000 | $7,485,000 | $7,680,000 | $7,019,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,615 | 111,317 | 111,092 | 110,707 | 112,435 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 9,222,000 | 9,080,000 | 8,935,000 | 8,825,000 | 8,711,000 |
| Other shareholders' equity | 17,000 | 20,000 | 21,000 | 21,000 | 18,000 |
| TOTAL | $6,841,000 | $6,656,000 | $6,469,000 | $6,342,000 | $6,463,000 |
| Total Liabilities And Equity | $16,095,000 | $13,881,000 | $13,954,000 | $14,022,000 | $13,482,000 |